Puma Biotechnology Investor Relations Material

Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of products to enhance cancer care in the United States and internationally. The company is focused on late-stage development of tarextumab tetraxetan for the treatment of certain advanced cancers, as well as development and commercialization of bevasiranib phosphate for the treatment of gastrointestinal stromal tumors (GIST).